We are a multi-disciplinary translational prostate cancer research group based at the University of Cambridge Early Cancer Institute.
The aim of our research is to transform the lives of prostate cancer sufferers.
This is achieved through the development and application of cutting-edge technologies including; patient-derived organoids, functional genomic screening, and application of single-cell and multi-omic sequencing approaches to clinical trial specimens.
Meet the team...
Ping Jing Toong